Kyowa Kirin Asia Pacific is dedicated towards our patient health and wellbeing worldwide. We leverage on innovative drug discovery and global commercialisation, driven by state of-the-art antibody technologies mainly in the core therapeutic areas of Nephrology, Oncology, Immunology & Allergy, and Central Nervous System.
In Asia Pacific
In Asia Pacific, we aim to be the best in class specialty pharmaceutical company in our therapeutic areas, and partner of choice for the commercialisation of specialty drugs.
Kyowa Kirin Asia Pacific aspires to collaborate with our counterparts to contribute to the health and well-being of people around the world by creating new value through the pursuits of advances in life sciences and technologies.